Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06687369
PHASE3

A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)

Sponsor: mAbxience Research S.L.

View on ClinicalTrials.gov

Summary

This is a randomized, multicenter, multinational, double-blind, integrated pharmacokinetics (PK) and efficacy similarity study to compare the PK, efficacy, safety, and immunogenicity of MB12 versus Keytruda® in combination with pemetrexed-platinum chemotherapy as first-line treatment in patients with metastatic non-squamous NSCLC.

Official title: Randomized, Multicenter, Multinational, Double-Blind Study to Compare the Pharmacokinetics, Efficacy, Safety and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) Versus Keytruda® in Combination With Chemotherapy for the Treatment of Patients With Advanced Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (BENITO Study)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

726

Start Date

2024-12-30

Completion Date

2027-09

Last Updated

2026-09-10

Healthy Volunteers

No

Interventions

DRUG

MB12 (Proposed Pembrolizumab Biosimilar)

200mg IV, every 3 weeks on Day 1

DRUG

EU-sourced Keytruda®

200mg IV, every 3 weeks on Day 1

DRUG

US-sourced Keytruda®

200mg IV, every 3 weeks on Day 1

DRUG

Pemetrexed

500 mg/m2 IV, every 3 weeks on Day 1

DRUG

Carboplatin

Area under the curve (AUC) 5 IV, every 3 weeks on Day 1 for 4 cycles.

DRUG

Cisplatin

75 mg/m2 IV, every 3 weeks on Day 1 for 4 cycles

Locations (173)

Site 101001

Yerevan, Armenia

Site 101002

Yerevan, Armenia

Site 101003

Yerevan, Armenia

Site 101004

Yerevan, Armenia

Site 103001

Sarajevo, Bosnia and Herzegovina

Site 103002

Tuzla, Bosnia and Herzegovina

Site 103003

Zenica, Bosnia and Herzegovina

Site 301014

Barretos, Brazil

Site 301026

Belém, Brazil

Site 301002

Belo Horizonte, Brazil

Site 301023

Bento Gonçalves, Brazil

Site 301006

Blumenau, Brazil

Site 301019

Caxias do Sul, Brazil

Site 301015

Curitiba, Brazil

Site 301028

Curitiba, Brazil

Site 301024

Florianópolis, Brazil

Site 301010

Fortaleza, Brazil

Site 301011

Ijuí, Brazil

Site 301008

Itajaí, Brazil

Site 301012

Jaú, Brazil

Site 301018

Natal, Brazil

Site 301003

Porto Alegre, Brazil

Site 301005

Porto Alegre, Brazil

Site 301007

Porto Alegre, Brazil

Site 301016

Porto Alegre, Brazil

Site 301022

Recife, Brazil

Site 301009

Rio de Janeiro, Brazil

Site 301020

Santo André, Brazil

Site 301001

São José do Rio Preto, Brazil

Site 108004

Batumi, Georgia

Site 108005

Kutaisi, Georgia

Site 108011

Marneuli, Georgia

Site 108001

Tbilisi, Georgia

Site 108002

Tbilisi, Georgia

Site 108003

Tbilisi, Georgia

Site 108006

Tbilisi, Georgia

Site 108007

Tbilisi, Georgia

Site 108008

Tbilisi, Georgia

Site 108009

Tbilisi, Georgia

Site 108010

Tbilisi, Georgia

Site 108012

Tbilisi, Georgia

Site 110006

Athens, Greece

Site 110003

Kifissia, Greece

Site 110004

Larissa, Greece

Site 110009

Pátrai, Greece

Site 110001

Thessaloniki, Greece

Site 110002

Thessaloniki, Greece

Site 110005

Thessaloniki, Greece

Site 110008

Thessaloniki, Greece

Site 110010

Volos, Greece

Site 113012

Brescia, Italy

Site 113010

Cremona, Italy

Site 113007

Genova, Italy

Site 113011

Lecce, Italy

Site 113009

Meldola, Italy

Site 113001

Pavia, Italy

Site 113003

Roma, Italy

Site 113006

Roma, Italy

Site 113005

Siena, Italy

Site 113008

Torino, Italy

Site 207002

Hakodate-shi, Japan

Site 207012

Okayama, Japan

Site 207010

Shinagawa-Ku, Japan

Site 207001

Shizuoka, Japan

Site 114001

Amman, Jordan

Site 114002

Amman, Jordan

Site 114003

Amman, Jordan

Site 114004

Amman, Jordan

Site 114005

Amman, Jordan

Site 114007

Amman, Jordan

Site 114006

Irbid, Jordan

Site 202001

Cheras, Malaysia

Site 202002

Kota Bharu, Malaysia

Site 202003

Kuala Selangor, Malaysia

Research site 116001

Chisinau, Moldova

Site 304001

Panama City, Panama

Site 304002

Panama City, Panama

Site 304003

Panama City, Panama

Site 203006

Bacolod City, Philippines

Site 203003

Baguio City, Philippines

Site 203004

Iloilo City, Philippines

Site 203009

Iloilo City, Philippines

Site 203005

Makati City, Philippines

Site 203007

Manila, Philippines

Site 203002

Quezon City, Philippines

Site 118004

Katowice, Poland

Site 118001

Lodz, Poland

Site 118005

Lublin, Poland

Site 118002

Prabuty, Poland

Site 118003

Słupsk, Poland

Site 119001

Lisbon, Portugal

Site 119002

Matosinhos Municipality, Portugal

Site 119003

Porto, Portugal

Site 120001

Cluj-Napoca, Romania

Site 120003

Craiova, Romania

Site 120004

Craiova, Romania

Site 120006

Floreşti, Romania

Site 120005

Timișoara, Romania

Site 121001

Belgrade, Serbia

Site 121002

Belgrade, Serbia

And 73 more locations on ClinicalTrials.gov